Manhattan, KS, United States of America

Bradley W Fenwick

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Kansas State University Research Foundation, Other. Active years: 1998-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bradley W Fenwick. Retrieved from https://idiyas.com/inventor/bradley-w-fenwick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1998-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Bradley W Fenwick

Introduction

Bradley W Fenwick is a notable inventor based in Manhattan, KS (US). He has made significant contributions to the field of veterinary medicine and diabetes treatment, holding a total of 4 patents. His work focuses on developing innovative solutions that address critical health issues in both animals and humans.

Latest Patents

One of Fenwick's latest patents is for an improved kennel cough vaccine. This vaccine offers a low-cost solution for administration to living subjects, including mammals and birds. It features killed recombinantly modified microorganisms, which include recombinant DNA encoding protective proteins. These proteins are designed to prevent or reduce the severity of diseases in the subjects. The vaccine preparations do not require the separation of protective proteins from the host microorganisms, significantly decreasing the complexity and cost of the formulations. A preferred version of this vaccine includes microorganisms that express protective antigens such as pertactin and filamentous hemagglutinin protein products.

Another significant patent involves methods for treating cataracts and diabetic retinopathy using tricyclic pyrones. This innovation presents water-soluble, cell-permeable aldose reductase inhibitors that prevent the effects of galactosemia in patients. These compounds effectively prevent the accumulation of polyols and the changes in levels of protein kinase C gamma observed during diabetes and galactosemia.

Career Highlights

Fenwick has worked with the Kansas State University Research Foundation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and treatment of diseases affecting both animals and humans.

Collaborations

Throughout his career, Fenwick has collaborated with notable individuals such as Alan Brightman and Duy H Hua. These collaborations have further enriched his research and innovations.

Conclusion

Bradley W Fenwick's contributions to veterinary medicine and diabetes treatment through his innovative patents highlight his commitment to improving health outcomes. His work continues to influence the fields he is involved in, showcasing the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…